MARY MARTIN: Open Payments
NPI 1023114089 · MADISON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 69 payments from 21 companies in 2025. Trend: 2023 $1,087 · 2024 $1,118 · 2025 $1,233
Food & beverage: $1,233
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $255 |
| ABBVIE INC. | 11 | $169 |
| Esperion Therapeutics, Inc. | 5 | $103 |
| Abbott Laboratories | 5 | $102 |
| Novo Nordisk Inc | 5 | $93 |
| Lilly USA, LLC | 5 | $78 |
| Viatris Specialty LLC | 3 | $70 |
| Phathom Pharmaceuticals, Inc. | 5 | $59 |
| Exact Sciences Corporation | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
Products named: NEXLETOL, FREESTYLE LIBRE 3, VRAYLAR, BREZTRI, FARXIGA, YUPELRI, MOUNJARO, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
